Correlation Between China Asset and Jinhe Biotechnology

Can any of the company-specific risk be diversified away by investing in both China Asset and Jinhe Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China Asset and Jinhe Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between China Asset Management and Jinhe Biotechnology Co, you can compare the effects of market volatilities on China Asset and Jinhe Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China Asset with a short position of Jinhe Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of China Asset and Jinhe Biotechnology.

Diversification Opportunities for China Asset and Jinhe Biotechnology

0.31

Correlation Coefficient

China Asset  Jinhe Biotechnology

Weak diversification

The 3 months correlation between China and Jinhe is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding China Asset Management and Jinhe Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jinhe Biotechnology and China Asset is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China Asset Management are associated (or correlated) with Jinhe Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jinhe Biotechnology has no effect on the direction of China Asset i.e., China Asset and Jinhe Biotechnology go up and down completely randomly.

Pair Corralation between China Asset and Jinhe Biotechnology

Assuming the 90 days trading horizon China Asset Management is expected to generate 0.53 times more return on investment than Jinhe Biotechnology. However, China Asset Management is 1.89 times less risky than Jinhe Biotechnology. It trades about 0.42 of its potential returns per unit of risk. Jinhe Biotechnology Co is currently generating about -0.16 per unit of risk. If you would invest  324.00  in China Asset Management on October 9, 2024 and sell it today you would earn a total of  41.00  from holding China Asset Management or generate 12.65% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

China Asset Management  vs.  Jinhe Biotechnology Co

China Asset Management

Risk-Adjusted Performance

19 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in China Asset Management are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, China Asset sustained solid returns over the last few months and may actually be approaching a breakup point.

Jinhe Biotechnology

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Jinhe Biotechnology Co are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Jinhe Biotechnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with China Asset and Jinhe Biotechnology

The main advantage of trading using opposite China Asset and Jinhe Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China Asset position performs unexpectedly, Jinhe Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jinhe Biotechnology will offset losses from the drop in Jinhe Biotechnology's long position.

The idea behind China Asset Management and Jinhe Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.